original ) (raw )REFERENCES CONTENT ALERTS The d-Alanine Residues ofStaphylococcus aureus Teichoic Acids Alter the
Cuong Vuong
2000
View PDFchevron_right
Increased Glycan Chain Length Distribution and Decreased Susceptibility to Moenomycin in a Vancomycin-Resistant Staphylococcus aureus Mutant
Junko Kajimura
Antimicrobial Agents and Chemotherapy, 2002
View PDFchevron_right
Glycosylation of Staphylococcus aureus cell wall teichoic acid is influenced by environmental conditions
Philippe Talaga
Scientific Reports
View PDFchevron_right
Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall‐targeting antibiotic vancomycin
Rembert Pieper
…, 2006
View PDFchevron_right
Vancomycin resistance in Staphylococcus aureus may occur faster than expected
Kiran Tiwari
International Journal of Life Sciences, 2009
View PDFchevron_right
Cell Wall Composition and Decreased Autolytic Activity and Lysostaphin Susceptibility of Glycopeptide-Intermediate Staphylococcus aureus
Brian Wilkinson
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Vancomycin resistance in Staphylococcus aureus may occur faster than expected
Kiran Babu Tiwari
International Journal of Life Sciences, 2009
View PDFchevron_right
In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus
Patrice Francois
Journal of Antimicrobial Chemotherapy, 2001
View PDFchevron_right
Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureusMICROBIOLOGY Results
Pedro Matos
View PDFchevron_right
Mechanism of vancomycin resistance in methicillin resistant Staphylococcus aureus
Zdzislaw Markiewicz
Polish journal of microbiology / Polskie Towarzystwo Mikrobiologów = The Polish Society of Microbiologists, 2004
View PDFchevron_right
Increased Cell Wall Teichoic Acid Production and D-alanylation Are Common Phenotypes among Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Isolates
Christoph Mayer
PLoS ONE, 2013
View PDFchevron_right
Autolytic Properties of Glycopeptide-Intermediate Staphylococcus aureus Mu50
Brian Wilkinson
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Lysogenic conversion as a factor influencing the vancomycin tolerance phenomenon in Staphylococcus aureus
Dorota Zabicka
Journal of Antimicrobial Chemotherapy, 1997
View PDFchevron_right
Correlation of Daptomycin Resistance in a Clinical Staphylococcus aureus Strain with Increased Cell Wall Teichoic Acid Production and D-Alanylation
Patrice Francois
Antimicrobial Agents and Chemotherapy, 2011
View PDFchevron_right
Contribution of a Thickened Cell Wall and Its Glutamine Nonamidated Component to the Vancomycin Resistance Expressed by Staphylococcus aureus Mu50
Longzhu Cui
Antimicrobial Agents and Chemotherapy, 2000
View PDFchevron_right
Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus
Magda Atilano
Proceedings of the National Academy of Sciences, 2010
View PDFchevron_right
Characterization of Passage-Selected Vancomycin-Resistant Staphylococcus aureus Strains of Diverse Parental Backgrounds
Vineet Singh
Antimicrobial Agents and Chemotherapy, 2000
View PDFchevron_right
Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening
Thais Souto-padrón
International Journal of Antimicrobial Agents, 2006
View PDFchevron_right
VanA-Type Staphylococcus aureus Strain VRSA-7 Is Partially Dependent on Vancomycin for Growth
B. Perichon
Antimicrobial Agents and Chemotherapy, 2009
View PDFchevron_right
Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus
Hui-min Neoh
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Effect of vancomycin on the cytoplasmic membrane fatty acid profile of vancomycin-resistant and -susceptible isolates of Staphylococcus aureus
Zulfiqar Ali Mirani
View PDFchevron_right
Synergism between -Lactams and Glycopeptides against VanA-Type Methicillin-Resistant Staphylococcus aureus and Heterologous Expression of the vanA Operon
B. Perichon
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Molecular Basis of Vancomycin Dependence in VanA-Type Staphylococcus aureus VRSA-9
B. Perichon
Journal of Bacteriology, 2010
View PDFchevron_right
Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS
Patrice Francois
Journal of Antimicrobial Chemotherapy, 2014
View PDFchevron_right
Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus
Longzhu Cui
2003
View PDFchevron_right
Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50
Peter john Bennett
Journal of Antimicrobial Chemotherapy, 2002
View PDFchevron_right
Phenotypic Modifications in Staphylococcus aureus Cells Exposed to High Concentrations of Vancomycin and Teicoplanin
Carla C C R de Carvalho
Frontiers in microbiology, 2016
View PDFchevron_right
Influence of Wall Teichoic Acid on Lysozyme Resistance in Staphylococcus aureus
F. Gotz
Journal of Bacteriology, 2006
View PDFchevron_right
Disruption of D-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the β-lactam resistance modifier (-)-epicatechin gallate
Patricia Bernal
View PDFchevron_right
Characterization of IsaA and SceD, Two Putative Lytic Transglycosylases of Staphylococcus aureus
Marie Lysa
Journal of Bacteriology, 2007
View PDFchevron_right
Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses in Staphylococcus aureus
Eleftherios Mylonakis
ACS Chemical Biology, 2011
View PDFchevron_right
Staphylococcus aureus VRSA-11B Is a Constitutive Vancomycin-Resistant Mutant of Vancomycin-Dependent VRSA-11A
B. Perichon
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
In Vitro Activities of Daptomycin, Arbekacin, Vancomycin, and Gentamicin Alone and/or in Combination against Glycopeptide Intermediate-Resistant Staphylococcus aureus in an Infection Model
Mic Mus
Antimicrobial Agents and Chemotherapy, 2000
View PDFchevron_right